A new in vitro system will allow investigators to explore how immune system T cells develop specialized functions.

A study of 381 non-Vanderbilt physicians referred to the Vanderbilt Comprehensive Assessment Program (VCAP) in the Department of Psychiatry has shown that those referred for mental health, substance abuse and improper sexual boundary issues are less likely to receive a fit for duty recommendation than those referred for disruptive behavior.

A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.

Alkaline phosphatase enzymes appear to play roles in promoting pregnancy and in protecting the uterus from bacterial infection.

Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.

Utpal Davé, M.D., and Sandra Zinkel, M.D., Ph.D., have each received one-year, $100,000 “bridge grants” from the American Society of Hematology (ASH) to support research that has not been funded by the National Institutes of Health (NIH) due to budget cuts.

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.